COMBINATION OF BENZIMIDAZOLE ANTI-CANCER AGENT AND A SECOND ANTI-CANCER AGENT
    1.
    发明公开
    COMBINATION OF BENZIMIDAZOLE ANTI-CANCER AGENT AND A SECOND ANTI-CANCER AGENT 审中-公开
    KOMBINATION AUS EINEM BENZIMIDAZOLKREBSMITTEL UND EINEM ZWEITEN KREBSMITTEL

    公开(公告)号:EP2131840A1

    公开(公告)日:2009-12-16

    申请号:EP08724338.2

    申请日:2008-03-07

    申请人: S*BIO Pte Ltd

    IPC分类号: A61K31/4184

    摘要: The present invention relates to a pharmaceutical composition for the treatment of cancer as well as methods of treatment of cancer that are based on the finding that certain benzimidazole based anti-cancer agents can be used in combination with a second anti- cancer agent to achieve desirable therapeutic outcomes. More specifically the present invention relates to a pharmaceutical composition including a benzimidazole based anti-cancer agent and a second anti-cancer agent. The invention also relates to methods of treatment of cancer including administration of a benzimidazole based anti-cancer agent and a second anti-cancer agent to a patient in need thereof.

    摘要翻译: 本发明涉及一种用于治疗癌症的药物组合物以及癌症治疗方法,其基于某些基于苯并咪唑的抗癌剂可与第二种抗癌剂组合使用以达到理想的效果 治疗结果。 更具体地,本发明涉及包含基于苯并咪唑的抗癌剂和第二抗癌剂的药物组合物。 本发明还涉及治疗癌症的方法,包括向有需要的患者施用基于苯并咪唑的抗癌剂和第二抗癌剂。